Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Reproduction

Novel variants associated with premature ovarian insufficiency in Russian adolescents

Provisionally accepted
Polina  TsabaiPolina Tsabai*Zaira  KumykovaZaira KumykovaVictoria  AverkovaVictoria AverkovaNadezhda  PavlovaNadezhda PavlovaDmitry  MaslennikovDmitry MaslennikovAnna  BolshakovaAnna BolshakovaZalina  BatyrovaZalina BatyrovaTamara  KolpakovaTamara KolpakovaAndrey  BystritskiyAndrey BystritskiyNatalia  KaretnikovaNatalia KaretnikovaAlexey  EkimovAlexey EkimovAndrey  GoltsovAndrey GoltsovMar  V KuzMar V KuzAnna  TurchinetsAnna TurchinetsIrina  MukoseyIrina MukoseyTaisiya  KochetkovaTaisiya KochetkovaIgor  SadelovIgor SadelovJekaterina  ShubinaJekaterina ShubinaElena  UvarovaElena UvarovaSvetlana  YurenevaSvetlana YurenevaDmitry  TrofimovDmitry TrofimovGennady  SukhikhGennady Sukhikh
  • National Medical Research Center Of Obstetrics, Gynecology And Perinatology Named After Academician V.I. Kulakova, Moscow, Russia

The final, formatted version of the article will be published soon.

Abstract Introduction: While variants in hundreds of genes have been linked to premature ovarian insufficiency (POI), monogenic disorders account for fewer than half of idiopathic POI cases in adolescents with 46,XX karyotype. This highlights the need for the further genetic investigation across diverse populations. Patients and methods: We recruited 63 Russian patients diagnosed with 46,XX POI before age 18. All underwent FMR1 premutation testing and whole-exome sequencing (WES). Copy number variation (CNV) analysis was conducted on WES data. Segregation studies by Sanger sequencing were performed where samples from the patients' relatives were available. Results: We identified variants in 15 genes in 38% of the cohort, including 13 causative genes (FMR1, DCAF17, FOXL2, STAG3, TP63, BNC1, CPEB1, NOBOX, LMNA, FSHR, SPIDR, MCM8, EIF2B2) and 2 candidate genes (MYRF, LATS1). 3.2% of patients carried an FMR1 premutation. WES detected causative single nucleotide variants (SNVs) in 15 patients (17.5% of the cohort). CNV analysis increased the diagnostic yield to 20.6%, identifying 15q25.2 microdeletions (BNC1, CPEB1) in two patients and FSHR exon 2 deletion in one patient with resistant ovary syndrome. Overall, the combination of molecular genetic approaches established a diagnosis of monogenic POI (pathogenic or likely pathogenic variants) in 23.8% of adolescents with normal female karyotype. 5 patients (7.9%) carried variants of unknown significance in FSHR, LMNA, NOBOX, SPIDR, LATS1 genes, warranting further investigation. Discussion: Our findings demonstrate that WES is an effective diagnostic tool for adolescents with POI and should supplement standard karyotyping and FMR1 testing in routine clinical practice. We report several novel variants in POI-associated genes and propose new gene-disease association.

Keywords: PREMATURE OVARIAN INSUFFICIENCY, ovarian dysgenesis, whole-exome sequencing (WES), FMR1, Differences of sex development (DSD), Adolescent, Genetics

Received: 16 Aug 2025; Accepted: 05 Nov 2025.

Copyright: © 2025 Tsabai, Kumykova, Averkova, Pavlova, Maslennikov, Bolshakova, Batyrova, Kolpakova, Bystritskiy, Karetnikova, Ekimov, Goltsov, Kuz, Turchinets, Mukosey, Kochetkova, Sadelov, Shubina, Uvarova, Yureneva, Trofimov and Sukhikh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Polina Tsabai, polinatsabai@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.